Nomogram model for predicting causespecific mortality in patients with stage I small-cell lung cancer: A competing risk analysis

The five-year cumulative incidence rate in patients diagnosed with stage I small-cell lung cancer (SCLC) who were instructed to undergo surgery was from 40 to 60%.The death competition influence the accuracy of the classical survival analyses.